SYN - Synthetic Biologics Inc's (SYN) CEO Steve Shallcross on Q4 2020 Results - Earnings Call Transcript
Synthetic Biologics, Inc. (SYN) Q4 2020 Earnings Conference Call March 4, 2021 04:30 pm ET Company Participants Vincent Perrone - Director, Corporate Communication Steve Shallcross - Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary, Director Mike Kaleko - Senior Vice President Research and Development Vince Wacher - Head, Product and Corporate Development Conference Call Participants Jim Molloy - Alliance Global Partners Michael Okunewitch - Maxim Group Presentation Operator Good afternoon, and welcome to the Synthetic Biologics' 2020 Year End Investor Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communication at Synthetic Biologics. Please go ahead. Vincent Perrone Thanks, Gary and good afternoon, everyone. Welcome to Synthetic Biologics 2020 year
For further details see:
Synthetic Biologics, Inc's (SYN) CEO Steve Shallcross on Q4 2020 Results - Earnings Call Transcript